Skip to content

disease.nz

Your Daily Health News
Main navigation
Medical Editor August 24, 2021

Genevant pens $303M biobucks pact with Takeda, aiming at rare liver diseases using gene therapy – FierceBiotech

  1. Genevant pens $303M biobucks pact with Takeda, aiming at rare liver diseases using gene therapy  FierceBiotech
  2. Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nonviral Gene Therapies for Up to Two Rare Liver Diseases  Business Wire
  3. View Full coverage on Google News
Bookmark the permalink.

Recent Posts

  • Good viruses may treat inflammatory bowel disease – Stuff
  • 3387 new Covid cases; 12 more deaths with disease – Otago Daily Times
  • Reprogramming the Brain’s Cleaning Crew to Mop Up Alzheimer’s Disease – Neuroscience News
  • Swapping salt for substitutes reduces risk of stroke and heart conditions – study – The Guardian
  • Covid, Polio, Monkeypox, Langya Are a Warning on Disease Spread – Bloomberg

Recent Comments

    Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
    Footer navigation
    • Privacy Policy